How do I incorporate Beligas Etho-Primobolan into a modern periodised steroid cycle?

Etho-Primobolan fits into modern periodised cycles as a lean-mass anchor, a low-androgenicity base, or a blast-to-cruise bridge compound. Most structured protocols introduce it from week 1 of a defined training block, running it alongside a testosterone base. Its stable weekly plasma profile — derived from the enanthate ester's 10–14 day active window — makes it compatible with multi-compound stacks without creating pharmacokinetic interference.

When in a cycle should you start Methenolone Enanthate for best results?

Start Methenolone Enanthate from the first week of your cycle to maximise the progressive concentration build-up phase. Because steady-state plasma levels typically establish over weeks 2–4 with enanthate-class compounds, early introduction aligns the compound's peak anabolic contribution with the mid-cycle training intensity peak — the approach recommended in most evidence-informed cycle planning guides.

How long should a modern Primobolan cycle run to make effective use of a 10ml vial?

A modern Methenolone Enanthate cycle runs optimally at 12–20 weeks, reflecting the compound's gradual tissue-remodelling kinetics. One 10ml vial at 100mg/ml provides 1,000mg total — approximately 10 weeks of supply at a 100mg/day weekly-equivalent dose. Many practitioners use two or three vials for a full 16–20 week lean-mass block, often paired with testosterone at a maintenance dose.

Can you use insulin syringes to inject Etho-Primobolan from a 10ml vial at 100mg/ml?

Yes — the 100mg/ml concentration is specifically suited to insulin-syringe dosing for smaller, more frequent injections. A 1ml insulin syringe delivers exactly 100mg per draw, removing the need for dose calculation. The oil viscosity at this concentration is compatible with 27–29 gauge insulin needles, though subcutaneous administration of sterile oil-based injectables should be confirmed with a medical professional.

How should a 10ml Etho-Primobolan vial be stored after first opening?

After first puncture, store the vial upright at room temperature (15–25°C), away from direct light and heat sources; refrigeration is unnecessary but does not harm the solution. The rubber stopper maintains sterility between draws when standard aseptic technique is used. Inspect the solution before each draw — discard if you observe particulate matter, cloudiness, or discolouration. Most manufacturers recommend using multi-dose vials within 28 days of first puncture. (2) angle_used

High Concentration

Beligas Pharmaceuticals

Etho-Primobolan 100mg/ml 10ml Vial by Beligas Pharmaceuticals

Name: Etho-Primobolan 100mg/ml 10ml Vial by Beligas Pharmaceuticals
Brand: Beligas Pharmaceuticals
SKU: INJ-METE-BEL-100-003
Price: 68.00 EUR
Availability: InStock
Rating: 5 (2 reviews)

5 (2 reviews)

Etho-Primobolan by Beligas Pharmaceuticals is a Methenolone Enanthate injectable at 100mg/ml in a 10ml multi-dose vial, engineered to integrate seamlessly into evidence-informed modern cycling strategies — whether as a base compound, a dry-tissue phase anchor, or a bridging agent between heavier blasts. Its long-acting ester supports once- or twice-weekly injection schedules that align with the structured periodisation models favoured by contemporary competitive and recreational athletes. Quality is verified across the full production chain: each batch undergoes HPLC potency assay and LAL endotoxin testing under Beligas's GMP-certified manufacturing framework.

€68.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Supports stable weekly plasma levels aligned with modern once- or twice-weekly injection scheduling.
Functions as a lean-tissue preservation agent during caloric-deficit training phases.
Compatible with TRT-base and blast-cruise protocols without elevating androgenic load significantly.
10ml multi-dose vial provides sufficient volume for a full 10–16 week cycle phase from a single container.
HPLC-confirmed 100mg/ml potency ensures dose-response predictability across the entire cycle.
Low conversion to oestrogen reduces the need for ancillary anti-oestrogen compounds mid-cycle.
GMP-certified production batch documentation supports transparent, auditable cycle record-keeping.

Phase	Dosage	Note
Introductory / Loading (Weeks 1–4)	200–300mg/week (2–3ml/week)	Establishes plasma concentration build-up; stack with testosterone base at 100–200mg/week for hormonal support.
Main Anabolic Block (Weeks 5–16)	400–600mg/week (4–6ml/week)	Peak protocol dose for lean-mass cycling; divide into 2 equal injections per week for pharmacokinetic stability.
Cruise / Bridge Phase (Weeks 12–20)	200mg/week (2ml/week)	Reduced dose for blast-to-cruise transitions; maintains anabolic stimulus while lowering suppression depth.
Taper / Pre-PCT Window (Final 2 weeks)	100–200mg/week (1–2ml/week)	Gradual dose reduction; last injection should precede PCT initiation by 14–18 days per enanthate-class elimination standards.

Key takeaways

Plan Etho-Primobolan from cycle week one to build steady-state levels early.
Use the 100mg/ml concentration for precise insulin-syringe dosing without calculation.
Run 12–20 week cycles to align with Methenolone's gradual remodelling kinetics.
Delay PCT by 14–18 days after the last injection to respect enanthate elimination.
Verify every vial's potency via HPLC documentation before committing to a protocol.

Methenolone Enanthate 100mg/ml as a Modern Cycle-Planning Tool

Etho-Primobolan is a long-acting anabolic injectable consisting of Methenolone bound to an enanthate ester at a concentration of 100mg per millilitre, purpose-built to occupy a defined role within structured, periodised cycle architecture. Modern cycle design has moved well beyond the simple bulk/cut binary: today's athletes plan compounds by function, window of action, and hormonal compatibility — and Methenolone Enanthate sits at the intersection of all three criteria. Compared to shorter-ester Methenolone Acetate (oral), the injectable enanthate form delivers stable plasma levels over a 10–14 day active window per dose, allowing weekly injections without pharmacokinetic interference between compounds in a stacked protocol.

Where Etho-Primobolan Fits in a Structured Modern Cycle

Beligas Etho-Primobolan functions as a lean-tissue preserving agent during caloric-deficit phases, as a mild anabolic base in low-androgenicity stacks, and as a bridge compound in periodised plans that alternate between higher-intensity blast phases and lower-suppression cruise phases. Athletes running so-called TRT-base protocols commonly pair Methenolone Enanthate with a testosterone anchor at 100–200mg/week, using Primobolan at 400–600mg/week (per widely reported anecdotal evidence from structured logging communities) to add anabolic stimulus without escalating androgenic load. The compound's binding affinity for the androgen receptor — approximately 157% relative to testosterone by in-vitro assay data cited in pharmacological literature — makes it an efficient anabolic signal even at moderate weekly doses.

Cycle Duration, Timing, and Integration Notes

Modern evidence-informed cycling places Methenolone Enanthate best in runs of 12–20 weeks, reflecting both the compound's slow tissue-remodelling kinetics and the logistical reality of a 10ml vial supplying approximately 10 weeks at 100mg/day-equivalent weekly splits. Cycle start timing is typically aligned with the first week of a defined training block — not mid-cycle — to leverage the progressive concentration build-up that occurs over weeks 2–4 as steady-state plasma levels are established. Post-cycle planning must account for the enanthate ester's elimination window: most modern PCT frameworks delay SERM initiation by 14–18 days after the final injection, a figure consistent with standard enanthate-class pharmacokinetics documented in endocrinology literature.

Quality Controls Supporting Reliable Protocol Outcomes

Beligas Pharmaceuticals subjects every Etho-Primobolan production batch to HPLC-verified concentration accuracy and LAL (Limulus Amebocyte Lysate) endotoxin screening, both performed under GMP-certified conditions. Dose-response predictability — critical to any periodised cycle — depends directly on confirmed potency at the stated 100mg/ml specification.

Usage

CYCLE MAPPING: Before drawing your first dose, write out your full cycle timeline — start date, weekly dose per compound, and projected last injection date — so PCT timing can be calculated in advance relative to Etho-Primobolan's elimination window.
VIAL INSPECTION: Hold the 10ml vial to light and confirm a clear, particle-free oil solution before each draw; do not use if the solution appears cloudy or contains visible particulate matter.
ASEPTIC PREPARATION: Swab the rubber stopper with a 70% isopropyl alcohol wipe and allow it to dry fully; use a fresh, sterile needle for every draw to maintain multi-dose vial integrity across your cycle.
DOSE MEASUREMENT: Draw the calculated weekly volume into your syringe — at 100mg/ml, each 1ml equals exactly 100mg; for a 400mg/week protocol split into two injections, draw 2ml per session.
INJECTION TECHNIQUE: Administer intramuscularly into a large muscle group (glute, lateral quad, or dorsogluteal); aspirate if using needles longer than 1 inch; inject slowly over 20–30 seconds to minimise injection-site discomfort common with oil-based vehicles.
CYCLE LOG & MONITORING: Record injection date, dose, and site for every administration; schedule mid-cycle bloodwork (LH, FSH, total testosterone, haematocrit, liver enzymes) at week 6–8 to confirm the hormonal environment aligns with your cycle plan before continuing.

Warnings

Contraindications: Etho-Primobolan must not be used by individuals with known or suspected androgen-sensitive malignancies, established cardiovascular disease, active hepatic impairment, or hypersensitivity to any component of the formulation. Women who are pregnant, breastfeeding, or planning conception must avoid all anabolic-androgenic steroids. Individuals under 21 years of age should not use injectable anabolic compounds, as the hypothalamic-pituitary-gonadal axis may not be fully mature.

Side Effects: Potential adverse effects include suppression of endogenous testosterone production (dose- and duration-dependent), mild androgenic effects such as accelerated scalp hair thinning in genetically predisposed individuals, and changes in serum lipid profiles including reduction in HDL cholesterol. Virilisation risk in female users — including voice deepening and clitoral enlargement — is present even with compounds considered mild by androgenic index. Injection-site reactions (transient swelling, localised discomfort) may occur.

Monitoring: Baseline and mid-cycle blood panels should include total testosterone, LH, FSH, haematocrit, ALT/AST, and a full lipid panel. Haematocrit above 52% warrants dose reduction or cycle interruption. Cardiovascular function, including blood pressure monitoring, is recommended throughout any cycle exceeding 12 weeks.

PCT: Post-cycle therapy using a SERM (e.g. Nolvadex or Clomid) should be initiated no sooner than 14–18 days after the final Etho-Primobolan injection, consistent with enanthate-class clearance timelines. Standard PCT duration is 4–6 weeks; follow-up bloodwork 4–6 weeks after PCT completion confirms axis recovery before any subsequent cycle is considered.

Frequently asked questions

How do I incorporate Beligas Etho-Primobolan into a modern periodised steroid cycle?: Etho-Primobolan fits into modern periodised cycles as a lean-mass anchor, a low-androgenicity base, or a blast-to-cruise bridge compound. Most structured protocols introduce it from week 1 of a defined training block, running it alongside a testosterone base. Its stable weekly plasma profile — derived from the enanthate ester's 10–14 day active window — makes it compatible with multi-compound stacks without creating pharmacokinetic interference.
When in a cycle should you start Methenolone Enanthate for best results?: Start Methenolone Enanthate from the first week of your cycle to maximise the progressive concentration build-up phase. Because steady-state plasma levels typically establish over weeks 2–4 with enanthate-class compounds, early introduction aligns the compound's peak anabolic contribution with the mid-cycle training intensity peak — the approach recommended in most evidence-informed cycle planning guides.
How long should a modern Primobolan cycle run to make effective use of a 10ml vial?: A modern Methenolone Enanthate cycle runs optimally at 12–20 weeks, reflecting the compound's gradual tissue-remodelling kinetics. One 10ml vial at 100mg/ml provides 1,000mg total — approximately 10 weeks of supply at a 100mg/day weekly-equivalent dose. Many practitioners use two or three vials for a full 16–20 week lean-mass block, often paired with testosterone at a maintenance dose.
Can you use insulin syringes to inject Etho-Primobolan from a 10ml vial at 100mg/ml?: Yes — the 100mg/ml concentration is specifically suited to insulin-syringe dosing for smaller, more frequent injections. A 1ml insulin syringe delivers exactly 100mg per draw, removing the need for dose calculation. The oil viscosity at this concentration is compatible with 27–29 gauge insulin needles, though subcutaneous administration of sterile oil-based injectables should be confirmed with a medical professional.
How should a 10ml Etho-Primobolan vial be stored after first opening?: After first puncture, store the vial upright at room temperature (15–25°C), away from direct light and heat sources; refrigeration is unnecessary but does not harm the solution. The rubber stopper maintains sterility between draws when standard aseptic technique is used. Inspect the solution before each draw — discard if you observe particulate matter, cloudiness, or discolouration. Most manufacturers recommend using multi-dose vials within 28 days of first puncture. (2) angle_used

Manufacturer

Beligas Pharmaceuticals' manufacturing standards for Etho-Primobolan are governed by a GMP certification framework that extends across three critical control domains: incoming API characterisation, in-process sterility management, and finished-product release testing. The API certification process requires that each Methenolone Enanthate lot arrive with a Certificate of Analysis specifying identity, purity, and residual solvent data — documentation that Beligas's quality team cross-validates via independent spectroscopic confirmation before any raw material enters the filling suite. In-process controls during sterile filling comply with ISO Class 5 (Grade A) environmental requirements at the point of fill, with continuous viable and non-viable particulate monitoring throughout each batch run. Finished vials of Etho-Primobolan are released to distribution only after a qualified batch review confirms HPLC assay results at 100mg/ml ± pharmacopoeial tolerance and LAL endotoxin values within specification. This multi-stage certification architecture — API qualification, cleanroom compliance, and dual analytical release criteria — represents the production standard Beligas applies uniformly across its injectable line.

Product details

Brand	Beligas Pharmaceuticals
Active ingredient	methenolone enanthate
Also known as	Primobolan Depot, Primo, Methenolon Enanthat, Etho-Primobolan, Beligas Pharmaceuticals Primobolan Depot
Strength	100 mg
Form	Vial
Pack size	1 piece
Item number	INJ-METE-BEL-100-003

Reviews

5/5

2 reviews

Rating: 5 out of 5 starsOllie14Verified purchaseAug 2, 2026
Lean gains, zero fuss
running this at 600mg/week for 12 weeks stacked with 300mg test e. Put on about 6lbs of dry lean tissue, lost a bit of body fat at the same time. no water, no gyno drama, joints felt better than usual. Bloodwork at week 10 showed hematocrit at 48%, lipids shifted a little but nothing alarming. Packaging was spot on, discreet as you'd want. Will reorder without hesitation.
Rating: 5 out of 5 starsGrant87Verified purchaseJun 26, 2026
Primo done right
400mg/week for 10 weeks as a lean bulk, kept calories at a slight surplus and the quality of what I added was just clean muscle, no puffiness at all. Pip was basically nonexistent after the first pin. Definitely pharmaceutical grade feel to it. Ships fast too, had it in 5 days

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Primobol 100mg/ml 10x1ml Ampoules by Balkan Pharmaceuticals

Established Brand

Primobol 100mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Primobol by Balkan Pharmaceuticals delivers Methenolone Enanthate at 100 mg/ml across ten glass-fusion sealed, single-dose ampoules — a format rooted in the original Schering AG clinical presentation that has defined this compound since its 1960s introduction for muscle-wasting indications. The 100 mg/ml concentration reflects the benchmark established during Methenolone's first decade of human clinical use, situating Primobol as a direct continuation of a molecule with more than sixty years of documented pharmacological history. Each ampoule is manufactured under GMP Annex 1 aseptic conditions at Balkan Pharmaceuticals' Chișinău facility; HPLC potency analysis and LAL endotoxin screening are completed at batch level before release.

€55.00

Rimobolan 100mg/ml 1x1ml Ampoules by Schering

GMP Standard

Rimobolan 100mg/ml 1x1ml Ampullen by Schering

Rimobolan by Bayer is a pharmaceutical-grade injectable anabolic agent delivering Methenolone Enanthate at 100 mg/ml in a single-use 1 ml glass ampoule, produced under EU Good Manufacturing Practice regulations governed by the European Medicines Agency (EMA) framework. Each batch undergoes rigorous release testing — including HPLC-based potency verification and LAL (Limulus Amebocyte Lysate) endotoxin screening — before leaving Bayer's licensed production site. Quality assurance is built into every stage: from raw-material qualification through in-process controls to final certificate of analysis.

€6.00

Long-Acting Formula

Primabolin-100 100mg/ml 10ml Vial by BM Pharmaceuticals

Primabolin-100 is an oil-based injectable anabolic agent delivering Methenolone Enanthate at 100mg/ml — a concentration engineered for predictable, sustained plasma release governed by the enanthate ester's extended pharmacokinetic profile. With an active half-life of approximately 10–14 days, blood concentrations remain stable between injections, eliminating the rapid oscillations characteristic of short-ester Methenolone preparations. Quality assurance is embedded at the batch level: every 10ml vial passes HPLC potency verification and LAL endotoxin testing within a GMP-certified production environment operated by BM Pharmaceuticals.

€63.00

Brand Quality

PrimoTrex 150mg/ml 10ml Vial by Concentrex Labs

PrimoTrex by Concentrex Labs is a Methenolone Enanthate injectable formulated at 150 mg/ml in a 10 ml multi-dose vial, purpose-built for athletes who structure their training year around alternating high-output blast phases and lower-intensity cruise phases. The elevated 150 mg/ml concentration delivers meaningful dose flexibility within a single vial, reducing the number of injections required across both protocol phases. Quality release for each batch covers HPLC-verified potency and LAL endotoxin compliance; the finished vial clears distribution only after both assays confirm specification.

€60.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00